heparin: be given during pregnancy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.72
, blood
Weight: 0.57
, agent
Weight: 0.56
, molecule
Weight: 0.56
Siblings acetaminophen
Weight: 0.37
, fentanyl
Weight: 0.37
, warfarin
Weight: 0.36
, vancomycin
Weight: 0.36

Related properties

Property Similarity
be given during pregnancy 1.00
be used in pregnancy 0.93
be in pregnancy 0.92
be safe during pregnancy 0.90
be safe in pregnancy 0.87
be given to newborns 0.81
be given in ivf 0.80
is given 0.77
be given before surgery 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.74
Similarity weight: 0.77
Evidence: 0.36
¬ Remarkable(heparin, be given during pregnancy)
Evidence: 0.72
¬ Remarkable(warfarin, is given)
0.07
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 0.77
Evidence: 0.36
¬ Remarkable(heparin, be given during pregnancy)
Evidence: 0.94
¬ Remarkable(vancomycin, is given)

Remarkability from sibling implausibility

0.46
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.77
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.94
Remarkable(vancomycin, is given)
Evidence: 0.24
¬ Plausible(vancomycin, is given)
0.44
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.72
Remarkable(warfarin, is given)
Evidence: 0.57
¬ Plausible(warfarin, is given)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.65
¬ Salient(heparin, be given during pregnancy)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.90
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.21
¬ Salient(heparin, be safe during pregnancy)
0.70
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.93
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.68
¬ Typical(heparin, be used in pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.90
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.31
¬ Plausible(heparin, be safe during pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.90
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.59
¬ Typical(heparin, be safe during pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.92
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.75
¬ Typical(heparin, be in pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.90
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.15
¬ Remarkable(heparin, be safe during pregnancy)
0.65
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.87
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.33
¬ Salient(heparin, be safe in pregnancy)
0.65
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.87
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.73
¬ Typical(heparin, be safe in pregnancy)
0.64
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.93
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.61
¬ Plausible(heparin, be used in pregnancy)
0.64
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.87
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.22
¬ Remarkable(heparin, be safe in pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.87
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.48
¬ Plausible(heparin, be safe in pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.92
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.66
¬ Plausible(heparin, be in pregnancy)
0.62
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.77
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.35
¬ Typical(heparin, is given)
0.61
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.93
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.64
¬ Salient(heparin, be used in pregnancy)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.80
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.69
¬ Typical(heparin, be given in ivf)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.81
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.79
¬ Typical(heparin, be given to newborns)
0.60
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.92
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.69
¬ Salient(heparin, be in pregnancy)
0.58
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.81
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.47
¬ Salient(heparin, be given to newborns)
0.57
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.77
Evidence: 0.84
Typical(heparin, be given during pregnancy)
Evidence: 0.82
¬ Typical(heparin, be given before surgery)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.45
¬ Plausible(heparin, is given)
0.57
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.81
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.59
¬ Plausible(heparin, be given to newborns)
0.57
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.81
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.29
¬ Remarkable(heparin, be given to newborns)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.57
¬ Plausible(heparin, be given in ivf)
0.56
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.80
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.53
¬ Salient(heparin, be given in ivf)
0.54
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.92
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.50
¬ Remarkable(heparin, be in pregnancy)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.52
¬ Salient(heparin, be given before surgery)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.30
¬ Remarkable(heparin, be given before surgery)
0.53
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.93
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.52
¬ Remarkable(heparin, be used in pregnancy)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.63
¬ Plausible(heparin, be given before surgery)
0.52
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.77
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.61
¬ Salient(heparin, is given)
0.51
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.80
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.40
¬ Remarkable(heparin, be given in ivf)
0.32
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.77
Evidence: 0.36
Remarkable(heparin, be given during pregnancy)
Evidence: 0.82
¬ Remarkable(heparin, is given)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.65
Salient(heparin, be given during pregnancy)
Evidence: 0.84
¬ Typical(heparin, be given during pregnancy)
Evidence: 0.36
¬ Remarkable(heparin, be given during pregnancy)

Typical implies Plausible

0.36
Rule weight: 0.48
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.69
Plausible(heparin, be given during pregnancy)
Evidence: 0.84
¬ Typical(heparin, be given during pregnancy)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.36
¬ Remarkable(heparin, be given during pregnancy)
Evidence: 0.05
¬ Typical(vancomycin, is given)
0.08
Rule weight: 0.14
Evidence weight: 0.80
Similarity weight: 0.77
Evidence: 0.36
¬ Remarkable(heparin, be given during pregnancy)
Evidence: 0.55
¬ Typical(warfarin, is given)